Skip to main content

Published locations for FDA warns of higher death risk with Pepaxto in multiple myeloma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA warns of higher death risk with Pepaxto in multiple myeloma

User login

  • Reset your password
  • /content/fda-warns-higher-death-risk-pepaxto-multiple-myeloma
  • /fedprac/article/243546/multiple-myeloma/fda-warns-higher-death-risk-pepaxto-multiple-myeloma
  • /hematologynews/article/243546/multiple-myeloma/fda-warns-higher-death-risk-pepaxto-multiple-myeloma
  • /oncologypractice/article/243546/multiple-myeloma/fda-warns-higher-death-risk-pepaxto-multiple
  • /fedprac/avaho/article/243546/multiple-myeloma/fda-warns-higher-death-risk-pepaxto-multiple-myeloma
  • /hematology-oncology/article/243546/multiple-myeloma/fda-warns-higher-death-risk-pepaxto-multiple
  • /breast-cancer-icymi/article/243546/multiple-myeloma/fda-warns-higher-death-risk-pepaxto-multiple
  • /b-cell-lymphoma-icymi/article/243546/multiple-myeloma/fda-warns-higher-death-risk-pepaxto-multiple